   1  
 
F ull Title:  Le u k o S E Q: W h ole Ge n o me Se q ue nci n g as a First -Li ne 
Di a g n ostic T o ol f or Le u k o d ystr o p hies  
S h ort Title  Le u k o S E Q  
eI R B N o.:  1 6 -1 3 2 1 3  
Pr ot oc ol D ate:  9/ 1 2 / 2 0 1 6 
A me n d me nt 3  D ate:  A pril 2 0 1 8 ( F ull 
A m d.)  A me n d me nt 4  D ate:  Dece m ber 2 0 1 8 ( F ull A m d.)  
A me n d me nt 6  D ate:  Ma y 2 0 1 9 ( F ull A m d.)  A me n d me nt 1 7  D ate:  Se pte m ber 2 0 2 4 ( F ull A m d.) 
Ple ase n ote t h at t he a b o ve list d oes n ot i ncl u de ‘ St aff C h a n ge’ a me n d me nts.  
 St u d y Pri nci p al I n vesti g at or  A deli ne Va n der ver, M D  
T he C hil dre n’s H os pi[INVESTIGATOR_316719] P hila del p hia  
3 6 1 5 Ci vic Ce nter Bl v d. A R C 5 1 6 H  
P hila del p hia, P A 1 9 1 0 4  
e mail: va n der vera @c h o p.e d u
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   [ADDRESS_417112] A T E M E N T 	 ............................................................................................................................................	 7 	
2	S T U D Y O B J E C TI V E S 	 ........................................................................................................................................	 7 	
2. 1	 PRI M A R Y OBJ E C TI V E (O R AI M 1) 	...............................................................................................................................	 7 	
2. 2	 SE C O N D A R Y OBJ E C TI V E (O R AI M 2) 	.........................................................................................................................	 [ADDRESS_417113] U D Y DE SI G N 	.....................................................................................................................	 8 	
	Scr e e ni n g	 Pr oc e d ur es 	.................................................................................................................................................	 8 	
	F oll o w -U p	 P eri o d	( 1 2	 M o nt hs	 F O L L O WI N G	 R E P O R T) 	 .................................................................................	 [ADDRESS_417114] u d y	 Sit es / T ot al	 N u m b er	 of	 S u bj ects	 Pr oj ect e d 	........................................................	 [ADDRESS_417115] U D Y PO P U L A TI O N ( W G S  CO H O R T )	 ...........................................................................................	 9 	
	I ncl usi o n	 Crit eri a	 &	I niti al	 C a n di d at e	 Ass ess m e nt	 .........................................................................................	 9 	
	I ncl usi o n	 Crit eri a	– 	All	 C a n di d at es 	.......................................................................................................................	 9 	
	Excl usi o n	 Crit eri a	 – 	All	 C a n di d at es 	 .......................................................................................................................	 [ADDRESS_417116] R A T E G Y 	 .........................................................................................................................................	 1 3 	
7. 5	 IN F O R M E D CO N S E N T / AS S E N T A N D HI P A A  AU T H O RI Z A TI O N 	.......................................................................	 [ADDRESS_417117] ati o n	f or	t h e	 Us e	 of	 D ec e d e nt	 P HI 	...........................................................................................	 1 5 	
7. 6	 PA Y M E N T T O SU BJ E C T S / FA MI LI E S 	 ..........................................................................................................................	 [ADDRESS_417118]  M RI   Ma g netic Res o na nce I ma gi n g  N G S   Ne xt Ge nerati o n Se q ue nci n g  P HI   P r otecte d Healt h I nf or mati o n  
PI   [INVESTIGATOR_1307] I n vesti gat or  
S A E   Seri o us A d verse E ve nt  S o C   Sta n dar d of Care  
V U S   Varia nt of U n k n o w n Si g nifica nce  W E S   W h ole E x o me Se q ue nci n g  W G S   W h ole Ge n o me Se q ue nci n g  
 
  
   5  
A B S T R A C T  
C o nte xt /B ac k gr o u n d : 
Le u k o d ystr o p hies, a n d ot her herita ble dis or ders of t he w hite matter of t he brai n, were 
pre vi o usl y resista nt t o ge netic c haracterizati o n, lar gel y d ue t o t he e xtr e me ge netic 
heter o ge neit y of m olec ular ca uses. W hile rece nt w or k has de m o nstrate d t hat w h ole ge n o me 
se q ue nci n g ( W G S) has t he p ote ntial t o dra maticall y i ncrease dia g n ostic efficie nc y, 
si g nifica nt q uesti o ns re mai n ar o u n d t he i m pact o n d o w nstrea m cli nical ma na ge me nt 
a p pr oac hes vers us sta n dar d dia g n ostic a p pr oac hes.  
O bjecti ves: ( Pri m ar y a n d I m p ort a nt Sec o n d ar y O bjecti ves)  Pri m ar y  
 
•  Esti mate t he perce nta ge of cases t hat e x perie nce a si g nifica nt c ha n ge i n dia g n ostic stat us  
as a direct c o nse q ue nce of w h ole ge n o me se q ue nci n g.  
Sec o n d ar y  
 
•  Esti mate t he perce nta ge of cases t hat e x perie nce a si g nifica nt c ha n ge i n d o w nstrea m 
cli nical ma na ge me nt as a direct c o nse q ue nce of a dia g n o stic res ult t hr o u g h w h ole ge n o me se q ue nci n g . 
St u d y Desi g n:  
O bser vati o nal st u d y pre dicate d o n p ositi ve fi n di n gs of a ra n d o mize d cr oss o ver st u d y, w hic h 
de m o nstrate d s u peri or dia g n ostic efficac y of W G S c o m pare d t o sta n dar d dia g n ostic testi n g. 
Setti n g/ P artici p a nts:  
T his is a si n gle -site st u d y l ocate d at t he C hil dre n’s H os pi[INVESTIGATOR_316719] P hila del p hia ( C H O P). St u d y 
recr uit me nt will c o nti n ue u ntil 1 0 0 tri os ( or d u os) ha ve bee n e nr olle d.  
St u d y I nter ve nti o ns a n d Me as ures:  
T his is a n o bser vati o nal st u d y of s u bjects w h o are e x pecte d t o recei ve C LI A -certifie d w h ole 
ge n o me se q ue nci n g as part of t heir cli nical care . Researc h-o nl y meas ures will i ncl u de b ot h retr os pecti ve a n d pr os pecti ve re vie w of me dical rec or ds. 
M ai n St u d y O utc o me Me as ures:  Cli nical utilit y o utc o mes will be assesse d usi n g me dical rec or d re vie w.  
[ADDRESS_417119] ure c o m p ose d of a x o ns s heat he d i n m yeli n, a 
glial cell -deri ve d li pi d -ric h me m bra ne1. Le u k o d ystr o p hies are fre q ue ntl y c haracterize d b y 
earl y o nset, s pasticit y a n d de vel o p me ntal dela y, a n d are de ge nerati ve i n nat ure1. As a w h ole, 
   6  
le u k o d ystr o p hies are relati vel y c o m m o n (a p pr o xi matel y [ADDRESS_417120] u die d) wit h hi g h 
ass ociate d healt h -care c osts; h o we ver, m ore t ha n half of t he s us pecte d le u k o d ystr o p hies d o 
n ot ha ve a  defi niti ve dia g n osis3, 4, a n d are ge nerall y classifie d as “le u k o d ystr o p hies of 
u n k n o w n eti ol o g y”. E ve n w he n a dia g n osis is ac hie ve d, t he dia g n ostic pr ocess lasts a n a vera ge of ei g ht years
[ADDRESS_417121] e x pe nses i n e xcess of $ 8, 0 0 0 o n a vera ge per 
patie nt, i ncl u di n g t he maj orit y of patie nts w h o ne ver ac hie ve a dia g n osis at all 6, 7. T hese 
dia g n ostic c halle n ges re prese nt a n ur ge nt a n d u nres ol ve d ga p i n k n o wle d ge a n d disease 
c haracterizati o n, as o btai ni n g a defi niti ve dia g n osis is of para m o u nt i m p orta nce f or 
le u k o d ystr o p h y patie nts8. T he dia g n ostic w or k u p be gi ns wit h fi n di n gs on cra nial Ma g netic 
Res o na nce I ma gi n g ( M RI) f oll o we d b y se q ue ntial tar gete d ge netic testi n g1, h o we ver ne xt 
ge nerati o n se q ue nci n g ( N G S) tec h n ol o gies offer t he pr o mise of ra pi d a n d m ore c ost 
effecti ve a p pr oa c hes. 
 N G S tec h n ol o gies ha ve t he p ote ntial t o re v ol uti o nize t he dia g n ostic pr ocess f or rare 
diseases, es peciall y t h ose s uc h as t he le u k o d ystr o p hies, w hic h ha ve see n s uc h hist oricall y 
l o w rates of dia g n osis. O ur i nter nati o nal w or ki n g gr o u p (s pear hea de d b y Drs. Van der ver, 
Taft, B o n k o ws k y, Ber nar d, Sc hiff ma n n, a n d va n der K naa p) has e xte nsi ve a n d gl o ball y 
rec o g nize d e x pertise i n deci p heri n g t he ge netics u n derl yi n g u ns ol ve d le u k o d ystr o p hies. 
T he y c ollecti vel y ha ve bee n t he lar gest c o ntri b ut or t o t he m o der n u n dersta n d i n g of 
le u k o d ystr o p h y eti ol o g y a n d pat h o bi ol o g y. T his b o d y of w or k o ver t he last deca des i ncl u des 
t he descri pti o n of Va nis hi n g W hite Matter Disease (EI F 2 B 1 -5 )[ADDRESS_417122] o me ( P O L 3 R A 
a n d B )2 1 -2 3, Le u k oe nce p hal o pat h y wit h Brai nste m a n d S pi [INVESTIGATOR_1304] C or d I n v ol ve me nt a n d Lactate 
Ele vati o n ( D A R S 2 )2 4, 2 5, Me gale nce p halic Le u k oe nce p hal o pat h y wit h s u bc ortical C y sts 
(M L C 1 a n d H E P A C A M )2 6, 2 7, Le u k oe nce p hal o pat h y wit h T hala mic i n v ol ve me nt a n d Lactate 
a n d Sl o w I m pr o ve me nt ( E A R S 2 )[ADDRESS_417123] se veral years, t he pace of disc o ver y has i ncrease d at a re mar ka ble rate d ue t o t he use of w h ole ge n o me se q ue nci n g ( W G S) a n d w h ole e x o me se q ue nci n g ( W E S). T his 
i ncl u des t he disc o ver y of a n o vel le u k o d ystr o p h y, H y p o m yeli nati o n wit h Brai n Ste m a n d 
S pi [INVESTIGATOR_1304] C or d I n v ol ve me nt a n d Le g S pasticit y ( H B S L) , w hic h is ca use d b y m utati o ns i n 
D A R S
3 0, as well as t he disc o ver y t hat H y p o m yeli nati o n wit h Atr o p h y of t he Basal Ga n glia 
a n d Cere bell u m ( H -A B C) is ca use d b y de n ov o  T U B B [ADDRESS_417124] c o h ort a nal ysis of W E S i n le u k o d ystr o p h y, wit h a dia g n ostic efficac y i n 
t he u ns ol ve d patie nts of nearl y 5 0 %, decreasi n g t he o verall pr o p orti o n of u ns ol ve d le u k o d ystr o p h y cases fr o m 5 0 % t o a p pr o xi matel y 2 5 %. 
Des pi[INVESTIGATOR_040] t hese a d va nces i n dia g n ostic efficac y, t here are still si g nifica nt iss ues wit h res pect t o 
i m ple me ntati o n of N G S i n cli nical setti n gs. First, sa m ple c o h orts de m o nstrati n g dia g n ostic 
efficac y are ge nerall y s mall, retr os pecti ve, a n d s usce pti ble t o asc ertai n me nt bias, ulti matel y 
re n deri n g t he m p o or ca n di dates f or utilit y a nal yses (t o deter mi ne h o w efficie nt a test is at 
pr o d uci n g a dia g n osis). Sec o n d, hist oric sa m ple c o h orts ha ve n ot bee n e xa mi ne d 
pr os pecti vel y f or i nf or mati o n a b o ut i m pact o n cli nical m a na ge me nt ( w het her t he test res ults 
i n differe nt cli nical m o nit ori n g, a c ha n ge i n me dicati o ns, or alter nate cli nical i nter ve nti o ns).  
T o a d dress t hese iss ues, t he st u d y tea m c o n d ucte d a n i n vesti gati o n of patie nts wit h 
s us pecte d le u k o d ystr o p hies or ot her ge netic dis or ders affecti n g t he w hite matter of t he brai n 
at t he ti me of i nitial c o nfir mati o n of M RI a b n or malities, wit h pr os pecti ve c ollecti o n of 
patie nts ra n d o ml y recei ve d o n a “first c o me, first ser ve d” basis fr o m a net w or k of e x pert 
   7  
cli nical sites. S u bjects were ra n d o mize d t o recei ve earl y ( 1 m o nt h) or late ( 6 m o nt hs) W G S, 
wit h  Sta n dar d of Care  (S o C ) cli nical a nal yses c o n d ucte d al o n gsi de W G S testi n g. A n i nteri m 
a nal ysis perf or me d i n Ma y [ADDRESS_417125] u d y o utc o mes f or a c o h ort of t hirt y -f o ur 
( 3 4) e nr olle d s u bjects. T w o of t hese s u bjects were res ol ve d bef ore c o m plete e nr oll me nt a n d 
were retai ne d as c o ntr ols. Ni ne s u bjects were stratifie d t o t he I m me diate Ar m, of w hic h 5 
( 5 5. 6 %) were res ol ve d b y W G S a n d 4 ( 4 4. 4 %) were persiste ntl y u nres ol ve d. Of t he 2 3 
s u bjects ra n d o mize d t o t he Dela ye d Ar m, 1 4 ( 6 0. 9 %) were res ol ve d b y W G S a n d 5 ( 2 1. 7 %) 
b y S o C, w hile t he re mai ni n g 4 ( 1 7. 4 %) re mai ne d u n dia g n ose d. T he dia g n ostic efficac y of 
W G S i n b ot h ar ms was si g nifica nt relati ve t o S o C ( p < 0. 0 0 5). T he ti me t o dia g n osis was 
si g nifica ntl y s h orter i n t he i m me diate W G S gr o u p ( p < 0. 0 5). T he o verall dia g n ostic efficac y 
of t he c o m bi nati o n of W G S a n d S o C a p pr oac hes was 2 6/ 3 4 ( 7 6. 5 %; 9 5 % CI = 5 8. 8 % t o 8 9. 3 %) o ver < [ADDRESS_417126] orical n or ms of < 5 0 % o ver m ore t ha n [ADDRESS_417127] u d y will be c o n d ucte d i n f ull acc or da nce wit h  all a p plica ble C hil dre n’s H os pi[INVESTIGATOR_316719] P hila del p hia Researc h  ( C H O P) P olicies a n d Pr oce d ures a n d all a p plica ble Fe deral a n d state 
la ws a n d re g ulati o ns, i ncl u di n g [ADDRESS_417128] u d y see ks t o deter mi ne w het her W G S res ults i n c ha n ges t o dia g n ostic stat us a n d 
cli nical ma na ge me nt i n s u bjects affecte d b y u n dia g n ose d ge netic dis or ders of t he w hite 
matter of t he brai n.  
2. 1  Pri m ar y O bjecti ve ( or Ai m  1 ) 
Esti m ate t he perce nt a ge of c ases t h at e x perie nce a si g nific a nt c h a n ge i n di a g n ostic 
st at us  as a direct c o nse q ue nce of w h ole ge n o me se q ue nci n g.  
 
T he pri mar y o bjecti ve of t his st u d y is t o e val uate c ha n ges i n dia g n ostic stat us i n t he st u d y 
c o h ort f or patie nts w h o recei ve d W G S as part of cli nical care. Differe nces i n dia g n ostic 
stat us will be meas ure d at  discl os ure of i nitial res ults or discl os ure of rea nal yze d res ults.   
 
T y pes of c ha n ge i n ma na ge me nt are defi ne d i n Secti o n 5. 1. 4.  
 
   8  
2. 2  Sec o n d ar y O bjecti ve ( or Ai m  2 ) 
Esti m ate t he perce nt a ge of c ases t h at e x perie nce a si g nific a nt c h a n ge i n d o w nstre a m 
cli nic al m a n a ge me nt as a direct c o nse q ue nce of a di a g n osis t hr o u g h w h ole ge n o me se q ue nci n g (s u bjects wit h a di a g n ostic res ult). 
T he sec o n dar y o bjecti ve of t his st u d y is t o e val uate c ha n ges i n cli nical care i n s u bjects w h o 
recei ve d a dia g n osis t hr o u g h W G S. Differe nces i n cli nical care will be e val uate d [ADDRESS_417129] u d y i de ntifiers t o P HI. 
M RIs will be a nal yze d acc or di n g t o a p u blicl y  a vaila ble n o n -c o m p utati o nal al g orit h m 
accessi ble t o e ve n n o n -e x pert c hil d ne ur ol o gists a n d ge neticists
4 6. Ca n di dates  ma y be 
e nr olle d irres pecti ve of t he cli nicia n’s pres u m pti ve dia g n osis (e ve n if t he cli nicia n feels t here is a n u na m bi g u o us dia g n osis base d o n M RI a n d i nitial cli nical assess me nt), as l o n g as 
n o c o nfir mat or y testi n g has bee n perf or me d . Eac h ca n di date’s M RIs m ust be re vie we d b y at 
least t w o of t he f o ur e x perts. If necessar y, ca n di dates  will be reclassifie d wit h res pect t o t heir pre-test dia g n ostic pr o ba bilities
. 
 F oll o w -U p Peri o d ( 12  M o nt hs  F O L L O WI N G R E P O R T ) 
S u bjects e nr olle d i n t he st u d y will c o nc urre ntl y u n der g o W G S as part of t heir cli nical care, 
wit h sa m ples se nt t o t he Ill u mi na Cli nical Ser vices La b orat or y (I C S L) f or cli nicall y -
vali date d testi n g.  
 
   [ADDRESS_417130] u d y Sites/ T ot al N u m ber of S u bjects Pr ojecte d  
T his is a si n gle -site st u d y l ocate d at t he C hil dre n’s H os pi[INVESTIGATOR_316719] P hila del p hia ( C H O P).  St u d y 
recr uit me nt will c o nti n ue u ntil 1 0 0  tri os ( or d u os) ha ve bee n e nr olle d.  
3. [ADDRESS_417131] u d y P o p ul ati o n ( W G S C o h ort)  
 I ncl usi o n Criteri a & I niti al C a n di d ate  Assess me nt  
T hese criteria ha ve bee n selecte d i n or der t o e ns ure t hat selecte d cases fit t he defi niti o n of a le u k o d ystr o p h y 
[ADDRESS_417132] et h nicities t o be re prese nte d  base d o n U .S . ce ns us data of p o p ulati o n distri b uti o n.  
 I ncl usi o n Criteri a –  All C a n di d ates  
1)  A b n or malities of t he w hite matter si g nal o n ne ur oi ma gi n g ( M RI) wit h T [ADDRESS_417133] be diff use or i n v ol ve s pecific a nat o mical tracts c o nsiste nt wit h a ge netic dia g n osis ;  
2)  N o pre -e xisti n g ge netic dia g n osis;  3)  A cli nical decisi o n has bee n ma de t o perf or m W G S ; 
4)  Less t ha n 1 8 years of a ge  (e xce pti o n f or affecte d si bli n g of t he pr o ba n d);  
5)  A vaila bilit y of b ot h bi ol o gic pare nts f or bl o o d sa m pli n g ; 
6)  A vaila bilit y of b ot h bi ol o gical pare nts  t o pr o vi de i nf or me d c o nse nt; 
7)  C o nc urre ntl y e nr olle d i n C H O P I R B 1 4 -0 1 1 2 3 6 ( M yeli n Dis or ders 
Bi ore p osit or y Pr oject ) 
 
 E xcl usi o n Criteri a  –  All C a n di d ates  
1)  Ca n di dates wit h ac q uire d dis or ders, i ncl u di n g i nfecti o n, ac ute disse mi nate d 
e nce p hal o m yelitis ( A D E M), m ulti ple scler osis, vasc ulitis or t o xic 
le u k oe nce p hal o pat hies; 
2)  Patie nts w h o ha ve ha d pre vi o us ne xt -ge nerati o n ge netic se q ue nci n g* , 
i ncl u di n g W E S or  W G S ; 
3)  T h ose wit h n o t hir d -part y pa yer i ns ura nce, u na ble t o recei ve sta n dar d of care 
dia g n osis a n d t hera pe utic a p pr oac hes ; 
   1 0  
4)  Ca n di dates w h o ha ve alrea d y recei ve d a dia g n osis . 
 
* N ote:  K ar y ot y pe or  micr oarra y testi n g t hat di d n ot yiel d a defi niti ve dia g n osis s h o ul d n ot 
be c o nsi dere d as a n e xcl u di n g fact or.  
 
 I ncl usi o n Criteri a - P are nts  
1)  Males or fe males 1 8 years or ol der ; 
2)  C hil d wit h a s us pecte d le u k o d ystr o p h y  or ot her s us pecte d ge netic dis or der 
affecti n g t he w hite matter of t he brai n.   
 E xcl usi o n Criteri a  - P are nts  
1)  I na bilit y t o pr o vi de c o nse nt; 2)  Pre g na nt w o me n a n d fet uses will n ot be i ncl u de d i n t his st u d y . 
 
Ca n di dates w h o d o n ot meet all of  t he e nr oll me nt criteria ma y n ot be e nr olle d. Vi olati o ns  of 
t hese criteria will be re p orte d i n acc or da nce wit h I R B P olicies a n d Pr oce d ures.  
[ADDRESS_417134] u d y O utc o me Me as ures  
 Pr os pecti ve C ollecti o n of Cli nic al Utilit y D at a  
Cli nical  utilit y o utc o mes will be assesse d usi n g a c o m bi nati o n of me dical rec or d re vie w  1 
year pri or t o (retr os pecti ve) a n d 1 year f oll o wi n g  ( pr os pecti ve) discl os ure of res ults.  A n 
a p pr o priatel y trai ne d me m ber of t he st u d y tea m will re vie w t his data f or d oc u me nte d  
c ha n ges i n care a n d cli nical state, i ncl u de d c ha n ges i n me dical m or bi dities, s ur geries, 
p har mac ol o gic ma na ge me nt of c o m plicati o ns a n d i m ple me ntati o n of disease s pecific 
t hera pi[INVESTIGATOR_014]. T he f oll o wi n g data ele me nts will be a bstracte d fr o m patie nt me dical rec or ds f or a nal ysis. 
•  D ia g n ostic stat us ( pri mar y): Res ults were dia g n ostic, n o n -dia g n ostic ( ne gati ve or 
varia nt of u n k n o w n si g nifica nce ( V U S ) wit h i nc o nsiste nt p he n ot y pe ), u ncertai n (pre vi o usl y a n d/ or n ot pre vi o usl y re p orte d V U S  i de ntifie d a n d re q uires f oll o w-u p ). 
•  I m plicati o ns of W G S: c o nfir me d a dia g n osis wit hi n t he differe ntial dia g n osis pri or t o 
testi n g, esta blis he d a ne w dia g n osis t hat was n ot pre vi o usl y s us pecte d, pr o d uce d a dia g n osis u nrelate d t o t he cli nical i n dicati o n f or testi n g [i ncl u des i nci de ntal fi n di n g s 
a n d/ or sec o n dar y fi n di n gs], r ule d o ut a s us pecte d dia g n osis/ dia g n oses, eli mi nate d 
t he nee d f or a d diti o nal tests or e val uati o ns, c o ntri b ute d t o t he o verall dia g n ostic 
e val uati o n of t his patie nt.  
o  Dia g n ostic  c ha n ges i n ma na ge me nt  if dia g n ostic res ult (sec o n dar y):   
Referrals t o Ne w Healt hcare Pr o vi ders (i nc. S pecialt y ) 
o  Disease -s pecific treat me nt or me dicati o n C ha n ges (i nc. T y pe a n d Detail)  
o  Disease -s pecific scree ni n g (i m ple me nte d ne w scree ni n g, scree ni n g 
i m ple me nte d f or s us pecte d d x was j ustifie d) 
o  Decisi o ns o n palliati ve care  
   [ADDRESS_417135] u d y ( T y pe) 
o  Fa mil y pla n ni n g, c o u nseli n g, or s u p p ort ( T y pe) 
 O utc o me Me as ure Defi niti o ns  
T he f oll o wi n g t y pes of c ha n ge i n ma na ge me nt will be c o nsi dere d.  
•  Rec o m me n de d c ha n ges i n f ut ure disease m o nit ori n g, as d oc u me nte d i n me dical 
rec or ds or base d o n c ha n ges t o pr o vi ders see n or i nter ve nti o ns rec o m me n de d; 
•  C ha n ges i n t he detecti o n a n d/ or ma na ge me nt of tar get c o m plicati o ns (e x. as pi[INVESTIGATOR_1313] o n 
p ne u m o nia) as d oc u me nte d i n me dical rec or ds or base d o n c ha n ges t o pr o vi ders see n 
or i nter ve nti o ns rec o m me n de d;  
•  Rec o m me n de d c ha n ges i n m o nit ori n g f or sec o n dar y c o m plicati o ns (e x. ca ncer 
s usce pti bilit y) as d oc u me nte d i n me dical rec or ds or base d o n c ha n ges t o pr o vi ders 
see n or i nter ve nti o ns rec o m me n de d; 
•  C ha n ges t o c o n diti o n s pecific ma na ge me nt (s pecific t hera p y relate d t o t he eti ol o g y 
of t he dia g n osis) as d oc u me nte d i n me dical rec or ds or base d o n c ha n ges t o pr o vi ders see n or i nter ve nti o ns rec o m me n de d; 
•  C ha n ges t o s pecific s u p p orti ve i nter ve nti o ns (s u p p orti ve care i nf or me d b y a better 
u n dersta n di n g of t he dia g n osis) as d oc u me nte d i n me dical rec or ds or base d o n c ha n ges t o pr o vi ders see n or i nter ve nti o ns rec o m me n de d;  
•  C ha n ges t o palliati ve or e n d -of -life care or a si g nifica nt c ha n ge t o e x pecte d 
o utc o mes (i nf or me d b y a better u n dersta n di n g of t he pr o g n osis) as d oc u me nte d i n me dical rec or ds or base d o n c ha n ges t o pr o vi ders see n or i nter ve nti o ns rec o m me n de d. 
4. [ADDRESS_417136] a n a n d S a m ple Size Deter mi n ati o n  
 A n al ysis f or Ai m 1  
T he pr o p orti o n of s u bjects w h o ha ve a c ha n ge i n dia g n osis stat us  a n d t he c o n diti o nal 
pr o p orti o n of s u bjects w h o were i m pacte d b y W G S will be calc ulate d f or t he c o h ort, 
wit h 9 5 % c o nfi de nce i nter vals ( 9 5 % CI).  In di vi d uals w h o were recr uite d t o t he 
pre vi o us (ra n d o mize d cr oss o ver) versi o n of t his pr ot oc ol  will be i ncl u de d. 
 A n al ysis f or Ai m 2  
T he fre q ue nc y a n d c o n diti o nal pr o p orti o n of s u bjects w h o recei ve d d o w nstrea m 
c ha n ges i n cli nical ma na ge me nt after a dia g n ostic res ult  t hr o u g h W G S will be calc ulate d f or t he c o h ort, wit h 9 5 % c o nfi de nce i nter vals ( 9 5 % CI). T he t y pe of d o w nstrea m cli nical c ha n ges will be re p orte d. I n di vi d uals w h o were recr uite d t o t he 
   1 2  
pre vi o us (ra n d o mize d cr oss o ver) versi o n of t his pr ot oc ol a n d recei ve d a dia g n osis 
t hr o u g h W G S will be i ncl u de d.  
 
 S a m ple Size Deter mi n ati o n  
 Ai m 1 : D ue t o t he r a pi d c h a n ges i n st a n d ar d of c are, m a ny of t he c o ntr ol ar m 
were i neli gi ble f or p artici p ati o n as a hist oric al c o ntr ol, si nce t hey receive d W G S 
t hr o u g h cli nic al c are. T hese c h a n ges t o st a n d ar d of c are als o hi n dere d st u dy 
e nr oll me nt s a m ple size g o als. T he t ot al s a m ple size t h at w as ac hieve d is N = 8 0 
(i ncl u di n g t he s u bjects e nr olle d i n t he r a n d o mize d c o ntrol ar m). P o wer 
c alc ul ati o ns are n o l o n ger nee de d f or c o m p aris o n t o c o ntr ol ar m.  
 Ai m [ADDRESS_417137] u d y is t he i na d verte nt 
discl os ure of pr otecte d healt h i nf or mati o n ( P HI) fr o m me dical rec or ds c ollecte d d uri n g t he 
f oll o w-u p peri o d . If a n y u na ntici pate d pr o ble ms relate d t o t he researc h i n v ol vi n g ris ks t o 
s u bjects or ot hers ha p pe n d uri n g t he c o urse of t his st u d y (i ncl u di n g S A Es) t he y will be 
re p orte d t o t he I R B i n acc or da nce wit h C H O P I R B S O P 4 0 8: U na ntici pate d Pr o ble ms 
I n v ol vi n g Ris ks t o S u bjects. A Es t hat are n ot seri o us b ut t hat are n ota ble a n d c o ul d i n v ol ve 
ris ks t o s u bjects will be s u m marize d i n narrati ve or ot her f or mat a n d s u b mitte d t o t he I R B at 
t he ti me of c o nti n ui n g re vie w.  
7  S T U D Y M A N A G E M E N T  
7. 1  D at a C ollecti o n a n d M a n a ge me nt  
S u bjec t me dical rec or ds will be ke pt i n l oc ke d file ca bi nets i n t he pri nci pal  i n vesti gat or’s 
office . O nl y t he a p pr o ve d st u d y staff will be a ble t o access t hese rec or ds.  De m o gra p hic  i nf or mati o n will be ke pt i n a pass w or d-pr otecte d R E D Ca p data base  accessi ble o nl y b y a p pr o ve d st u d y staff. W hile we d o n ot a ntici pate t he nee d t o re g ularl y c ollect pare ntal me dical rec or ds, t his w o ul d be ha n dle d i n a si milar fas hi o n.  
Wit h dra wal fr o m t he st u d y is per mitte d at a n y ti me a n d w o ul d res ult i n re m o val of a n y 
i de ntif yi n g i nf or mati o n fr o m rec or de d data bases.  
7. [ADDRESS_417138] o btai ni n g I R B a p pr o val. A  data use 
a gree me nt  ( D U A) will be e xec ute d bet wee n t he pr o vi der of t he data a n d a n y reci pie nt 
researc hers (i ncl u di n g t h ose at C H O P) bef ore s hari n g a li mite d dataset . F ull y de-i de ntifie d data  ma y be s hare d o n a case -b y -case basis.  
   [ADDRESS_417139] u d y partici pati o n i n v ol ves breac h of  c o nfi de ntialit y  d ue t o c ollecti o n, 
a nal ysis, a n d/ or rete nti o n of P HI  fr o m s u bject me dical rec or ds . 
 Ps yc h ol o gic al H ar ms  
All ge netic testi n g d o ne i n t his st u d y is part of t he c hil d’s cli nical care. We d o n ot a ntici pate 
a n y ps yc h ol o gical har ms . T his pr ot oc ol ma y gi ve false h o pe; t he pri nci pal i n vesti gat or a n d ge netic c o u nsel ors will atte m pt t o a v oi d t his.  
 
 Discri mi n ati o n  
T o t he f ullest e xte nt p ossi ble, t he i n vesti gat ors will n ot discl ose t o t hir d parties a n y i nf or mati o n a b o ut t he partici pa nts wit h o ut t heir e x presse d c o nse nt. 
 C o nfi de nti alit y of Me dic al I nf or m ati o n a n d S a m ples  
U p o n e nr oll me nt i n C H O P I R B [ADDRESS_417140] u d y i de ntifier (e x. L S_ 0 7 8)  ge nerate d b y 
st u d y staff. T he ke y will be l ocate d i n a pass w or d -pr otecte d R E D Ca p data base, accessi ble 
o nl y b y a p pr o ve d  st u d y staff. Na mes are mai ntai ne d i n t his data base i n or der t o pr o vi de 
patie nts wit h cli nicall y rele va nt i nf or mati o n ge nerate d fr o m t his st u d y. Wit h dra wal fr o m t he 
st u d y w o ul d res ult i n re m o val of a n y i de ntif yi n g i nf or mati o n fr o m rec or de d data bases a n d destr ucti o n of a n y bl o o d sa m ples.  
 P ote nti al Be nefits  
St u d y partici pati o n is n ot  i nte n de d t o c o nfer a n y direct be nefit  t o s u bjects. T he i n vesti gat ors 
are c o nfi de nt t hat t he k n o wle d ge glea ne d fr o m t his st u d y will s u p p ort wi der i m ple me ntati o n 
a n d access t o w h ole ge n o me se q ue nci n g . 
 Ris k -Be nefit Assess me nt  
T his is a n o m ore t ha n mi ni mal ris k pr ot oc ol, w here ris ks e nc o u ntere d are t he sa me as t h ose 
e nc o u ntere d i n r o uti ne cli nical care  wit h t he a d diti o n of t h ose ris ks relate d t o me dical rec or d re vie w.  
7. [ADDRESS_417141] u d y has bee n p oste d o n Cli nical Trials. g o v 
(N C T 0 2 6 9 9 1 9 0 ), a n d ma y be s hare d wit h cli nicia ns a n d/ or i n vesti gat ors at C H O P a n d ot her 
o utsi de i nstit uti o ns w h o r o uti nel y e nc o u nter patie nts wit h s us pecte d le u k o d ystr o p hies or 
ot her ge netic dis or ders affecti n g t he w hite matter of t he brai n.  
Referri n g pr o vi ders will as k t he st u d y ca n di date’s fa mil y t o c o m plete a R E D Ca p -base d 
‘ Referral S ur ve y’ use d b y t he C H O P Le u k o d ystr o p h y Ce nter t o c ollect  basic c o ntact a n d 
cli nical i nf or mati o n fr o m i n di vi d uals/fa milies i ntereste d i n sc he d uli n g a cli nical a p p oi nt me nt a n d/ or partici pati n g i n a researc h st u d y.  
   1 4  
7. 5  I nf or me d C o nse nt/ Asse nt a n d HI P A A A ut h oriz ati o n 
I nf or me d c o nse nt will t y pi[INVESTIGATOR_1306] y be d oc u me nte d i n t he c o nte xt of a s u bject’s cli nical 
e val uati o n at C H O P . T he s u bject will be gi ve n a t h or o u g h e x pla nati o n of t he st u d y, 
i ncl u di n g t he p ur p ose, pr oce d ures, ris ks a n d be nefits of partici pati o n, c o nfi de ntialit y, 
pr oce d ures f or wit h dra wal, a n d c o ntact i nf or mati o n f or st u d y pers o n nel. Fa milies will be 
i nf or me d t hat t heir me dical care at t hat i nstit uti o n will n ot be affecte d if t he y c h o ose n ot t o 
partici pate i n t he pr o p ose d researc h. If t he s u bject is i ntereste d i n e nr olli n g, a q ualifie d 
me m ber of t he st u d y tea m will e ns ure t hat i nf or me d c o nse nt is f ull y d oc u me nte d usi n g 
a p pr o ve d versi o ns of t he i nf or me d c o nse nt f or m (I C F).  
 
Met h o ds ot her t ha n a face -t o-face c o nse nt i nter vie w ma y be perf or me d if an eli gi ble s u bject 
is u na ble t o visit a partici pati n g st u d y site. I n t his sce nari o, st u d y staff will e ns ure t hat t his 
a p pr oac h all o ws f or a n a de q uate e xc ha n ge of i nf or mati o n a n d d oc u me ntati o n, a n d a met h o d 
t o e ns ure t hat t he si g ner of t he c o nse nt f or m is t he pers o n wh o pla ns t o e nr oll as a s u bject i n 
t he cli nical i n vesti gati o n or is le gall y a ut h orize d t o pr o vi de a si g nat ure o n be half of t he 
s u bject. T he I C F will be se nt t o t he s u bject b y p ostal mail, facsi mile, or e mail, a n d t he c o nse nt i nter vie w will t he n be c o n d ucte d b y tele p h o ne or a C H O P -a p pr o ve d vi de o 
c o nfere nci n g t o ol s uc h as We b E x, Bl ueJea ns, or Micr os oft Tea ms  after e ns uri n g t hat  t he 
s u bject has recei ve d a c o p y of t he i nf or me d  c o nse nt f or m  f or refere nce d uri n g t he 
disc ussi o n.  
 
F oll o wi n g  t he c o nse nt disc ussi o n, t he s u bject will si g n a n d date t he c o nse nt f or m a n d ret ur n 
t he d oc u me nt t o a n a ut h orize d me m ber of t he S t u d y T ea m b y p ostal mail, facsi mile, e mail, 
or b y u pl oa di n g it t o a C H O P -a p pr o ve d  file h osti n g ser vice s uc h as B o x, O ne Dri ve, G o o gle 
Dri ve, etc.  
 
A s u bject ma y als o be i n vite d t o si g n t he i nf or me d c o nse nt f or m electr o nicall y usi n g a n 
eletr o nic  si g nat ure via A d o be Si g n or  D oc u Si g n, or a n y ot her cl o u d-base d electr o nic 
si g nat ure platf or m t hat has bee n a p pr o ve d f or use b y t he C H O P Researc h I nstit ute. I n s uc h a 
case, f or ms  will be se nt f or si g nat ure via sec ure e mail. U p o n c o m pleti o n of all  re q uire d 
fiel ds, t he d oc u me nt will be  a ut o maticall y ret ur ne d t o a desi g nate d me m ber of t he st u d y 
tea m f or re vie w a n d fi nal si g nat ure. A  f ull y e xec ute d c o p y will t he n b e u pl oa de d t o t he 
s u bject’s researc h c hart i n R E D Ca p a n d ret ur ne d t o t he s u bject f or f ut ure refere nce. 
 
S u bjects w h o t ur n [ADDRESS_417142] reac hes t he a ge of maj orit y ( or, if c o g niti vel y i m paire d, t heir le gall y a ut h orize d re prese ntati ve).  
 
All reas o na ble eff orts will be ma de t o acc o m m o date n o n -E n glis h s pea ki n g s u bject s. If a 
Li mite d E n glis h Pr oficie nc y ( L E P) s u bject  is a ble t o visit a partici pati n g st u d y site f or 
e nr oll me nt, a certifie d cli nical i nter preter will ge nerall y be a vaila ble t o facilitate t he ‘ S h ort 
F or m C o nse nt’ pr ocess, w hic h has bee n a p pr o ve d f or use i n t his st u d y.  T he st u d y tea m will 
d oc u me nt t he i nter preter’s e m pl o yee I D n u m ber.  
 
If a ‘ S h ort F or m C o nse nt’ f or m is n ot a vaila ble i n a partic ular s u bject’s nati ve la n g ua ge, t he 
st u d y tea m will  s u b mit a n a me n d me nt t o t he C H O P I R B. T he a me n d me nt will i ncl u de a 
   1 5  
tra nslate d versi o n of ‘ S h ort F or m C o nse nt’ f or m i n t he la n g ua ge nee de d, al o n g wit h a 
certificate of tra nslati o n , a n d will nee d t o be a p pr o ve d pri or t o e nr olli n g t he s u bject.  
T he st u d y tea m will o btai n asse nt fr o m a d ults wit h di mi nis he d ca pacit y a n d c hil dre n ol der 
t ha n 7 years of a ge w he ne ver p ossi ble. If s u bjects u n der t he a ge of 1 8 years are u na ble t o 
pr o vi de asse nt , beca use t he y are eit her t o o y o u n g (less t ha n 7  years of a ge) , or t heir disease 
i nterferes wit h t heir a bilit y t o pr o vi de asse nt, t his reas o n will be d oc u me nte d o n t he 
c o nse nt/asse nt f or ms.  
U p o n occasi o n, s u bjects ma y bec o me l ost t o f oll o w -u p. T his a p plies i n partic ular t o re -
c o nse nt i n patie nts o ver t he a ge of [ADDRESS_417143] is u na ble t o tra vel t o a partici pati n g site, a n a ut h orize d tele p h o nic 
i nter pretati o n ser vice (e. g., ‘I nter pre Tal k’) will be use d t o facilitate t he ‘ S h ort F or m 
C o nse nt’ pr ocess.   
 
A  me m ber of t he st u d y tea m will s hare a n a p pr o ve d ‘S h ort F or m C o nse nt ’ d oc u me nt 
i n a la n g ua ge nati ve t o t he s u bject pri or t o t he c o nse nt i nter vie w. U p o n c o ncl usi o n of 
t he c o nse nt i nter vie w, t he s u bject will si g n t he ‘ S h ort F or m C o nse nt’ f or m, a n d a n 
i m partial wit ness/i nter preter w h o s pea ks b ot h t he s u bject’s nati ve la n g ua ge a n d 
E n glis h will be as ke d t o si g n t he ‘ S h ort F or m C o nse nt’ f or m a n d St u d y S u m mar y 
D oc u me nt”. T he wit ness/i nter preter's i n v ol ve me nt ( w he n n ot prese nt i n pers o n) will 
be d oc u me nte d.  
 
 HI P A A Attest ati o n f or t he Use of Dece de nt P HI  
A wai ver of HI P A A A ut h orizati o n has bee n re q ueste d t o use cli nical data o btai ne d fr o m decease d i n di vi d uals, as t his researc h will als o utilize t he P HI of dece de nts. I n acc or da nce 
wit h 4 5 C F R 1 6 4. 5 1 2(i)( 1)(iii), t he use or discl os ure bei n g s o u g ht is s olel y f or researc h o n 
t he pr otecte d healt h i nf or mati o n of dece de nts, t he pr otecte d healt h i nf or mati o n bei n g s o u g ht 
is necessar y f or t he researc h, a n d, at t he re q uest of t he c o vere d e ntit y ( C H O P), 
d oc u me ntati o n of t he deat h of t he i n di vi d uals a b o ut w h o m i nf or mati o n is bei n g s o u g ht ca n 
be pr o vi de d. Si nce dece de nts are n o l o n ger h u ma n s u bjects, t heir data/sa m ples i ncl u de d i n 
t his researc h will n ot be i ncl u de d i n t he e nr oll me nt n u m bers f or t his st u d y a n d researc h 
acti vities usi n g t hese sa m ples/ data will n ot be re p orte d as part of t he c o nti n ui n g re vie w. 
7. 6  P a y me nt t o S u bjects/ F a milies  
T here will be n o pa y me nt or gifts t o s u bjects or fa milies as part of t his pr ot oc ol . 
   [ADDRESS_417144] u d y ma y i n v ol ve fi n di n gs of n o vel ge nes i m plicate d i n disease, i de ntificati o n of a 
s pecific i n di vi d ual fr o m t he dia g n osis c o ul d be discer ne d i n p u blicati o ns or prese ntati o ns 
alt h o u g h t his is u nli kel y i n a c o h ort of 1 0 0 partici pa nts a n d t heir bi ol o gical pare nts. It is 
d o u btf ul t hat a n y de m o gra p hic i nf or mati o n c o ul d i de ntif y a n i n di vi d ual.  
  
   1 7  
 
9  R E F E R E N C E S  
1.  C ostell o DJ, Eic hler A F, Eic hler F S. Le u k o d ystr o p hies: classificati o n, dia g n osis, a n d 
treat me nt. T he ne ur ol o gist  2 0 0 9; 1 5 ( 6): 3 1 9-2 8.  
2.  B oes pfl u g -Ta n g u y O, La ba u ge P, F o gli A, Va urs -Barriere C. Ge nes i n v ol ve d i n 
le u k o d ystr o p hies: a gla nce at glial f u ncti o ns. C urre nt ne ur ol o gy a n d ne ur oscie nce re p orts  
2 0 0 8; 8 ( 3): [ADDRESS_417145] o n J L, Fill o u x F M, M u n d orff M B, Sri vasta va R. 
T he b ur de n of i n herite d le u k o d ystr o p hies i n c hil dre n. Ne ur ol o gy  2 0 1 0; 7 5 ( 8): 7 1 8-2 5.  
4.  va n der K naa p M S, Breiter S N, Nai d u S, Hart A A, Val k J. Defi ni n g a n d cate g orizi n g 
le u k oe nce p hal o pat hies of u n k n o w n ori gi n: M R i ma gi n g a p pr oac h. R a di ol o gy  1 9 9 9; 2 1 3 ( 1): 
[ADDRESS_417146] or W, H off ma n HJ. Relati ve i nci de nce of 
i n herite d w hite matter dis or ders i n c hil d h o o d t o ac q uire d pe diatric de m yeli nati n g dis or ders. 
Se mi n ars i n pe di atric ne ur ol o gy  2 0 1 2; 1 9 ( 4): 2 1 9-2 3.  
6.  Ric har ds J, K or ge ns ki E K, Sri vasta va R, B o n k o ws k y J L. C osts of t he dia g n ostic 
o d ysse y i n c hil dre n wit h i n herite d le u k o d ystr o p hies. Ne ur ol o gy  2 0 1 5; 8 5 ( 1 3): 1 1 6 7-7 0.  
7.  Ric har ds J, K or ge ns ki E K, Taft RJ, Va n der ver A, B o n k o ws k y J L. Tar gete d 
le u k o d ystr o p h y dia g n osis base d o n c har ges a n d yiel ds f or testi n g. A m J Me d Ge net A  2 0 1 5; 
1 6 7 A ( 1 1): 2 5 4 1-3.  
8.  K o hlsc h utter A, Eic hler F. C hil d h o o d le u k o d ystr o p hies: a cli nical pers pecti ve. 
Ex pert revie w of ne ur ot her a pe utics  2 0 1 1; 1 1 ( 1 0): 1 4 8 5-9 6.  
9.  Ba ms ha d MJ, N g S B, Bi g ha m A W, et al. E x o me se q ue nci n g as a t o ol f or Me n delia n 
disease ge ne disc o ver y. N at ure revie ws Ge netics  2 0 1 1; 1 2 ( 1 1): 7 4 5-5 5.  
1 0.  N g S B, Nic kers o n D A, Ba ms ha d MJ, S he n d ure J. Massi vel y parallel se q ue nci n g a n d 
rare disease. H u m a n m olec ul ar ge netics  2 0 1 0; 1 9 ( R 2): R 1 1 9-2 4.  
1 1.  Ma kr yt ha nasis P, Nelis M, Sa nt o ni F A, et al. Dia g n ostic E x o me Se q ue nci n g t o 
El uci date t he Ge netic Basis of Li kel y Recessi ve Dis or ders i n C o nsa n g ui ne o us Fa milies. 
H u m M ut at  2 0 1 4.  
1 2.  Ta yl or R W, P yle A, Griffi n H, et al. Use of w h ole -e x o me se q ue nci n g t o deter mi ne 
t he ge netic basis of m ulti ple mit oc h o n drial res pi[INVESTIGATOR_1305] y c hai n c o m ple x deficie ncies. J A M A : t he j o ur n al of t he A meric a n Me dic al Ass oci ati o n 2 0 1 4; 3 1 2 ( 1): 6 8-7 7.  
1 3.  Sri vasta va S, C o he n J S, Ver n o n H, et al. Cli nical W h ole E x o me Se q ue nci n g i n C hil d 
Ne ur ol o g y Practice. A n n als of ne ur ol o gy  2 0 1 4.  
1 4.  F o gel B L, Lee H, Dei g na n J L, et al. E x o me Se q ue nci n g i n t he Cli nical Dia g n osis of 
S p ora dic or Fa milial Cere bellar Ata xia. J A M A ne ur ol o gy  2 0 1 4.  
1 5.  Ya n g Y, M uz n y D M, Rei d J G, et al. Cli nical w h ole -e x o me se q ue nci n g f or t he 
dia g n osis of me n delia n dis or ders. T he Ne w E n gl a n d j o ur n al of me dici ne  2 0 1 3; 3 6 9 ( 1 6): 
1 5 0 2 -1 1.  
1 6.  Bea ulie u C L, Maje ws ki J, Sc h wartze ntr u ber J, et al. F O R G E Ca na da C o ns orti u m: 
o utc o mes of a [ADDRESS_417147]. A meric a n j o ur n al of 
h u m a n ge netics  2 0 1 4; 9 4 ( 6): [ADDRESS_417148] ual disa bilit y. T he Ne w E n gl a n d j o ur n al of me dici ne  2 0 1 2; 
3 6 7 ( 2 0): 1 9 2 1-9.  
1 8.  Sc hiff ma n n R, F o gli A, Va n der K naa p M S, B oes pfl u g -Ta n g u y O. C hil d h o o d Ata xia 
wit h Ce ntral Ner v o us S yste m H y p o m yeli nati o n/ Va nis hi n g W hite Matter. I n: Pa g o n R A, 
A da m M P, Bir d T D, D ola n C R, F o n g C T, Ste p he ns K, e ds. Ge ne Re vie ws. Seattle ( W A); 
1 9 9 3.  
1 9.  va n der K naa p M S, Bart h P G, Ga breels FJ, et al. A ne w le u k oe nce p hal o pat h y wit h 
va nis hi n g w hite matter. Ne ur ol o gy  1 9 9 7; 4 8 ( 4): [ADDRESS_417149] or eI F 2 B are m uta nt i n le u k oe nce p hal o pat h y wit h va nis hi n g w hite matter. N at ure ge netics  2 0 0 1; 2 9 ( 4): 3 8 3-8.  
2 1.  Ti m m o ns M, Ts o k os M, Asa b M A, et al. Peri p heral a n d ce ntral h y p o m yeli nati o n 
wit h h y p o g o na d otr o pic h y p o g o na dis m a n d h y p o d o ntia. Ne ur ol o gy  2 0 0 6; 6 7 ( 1 1): 2 0 6 6-9.  
2 2.  Ber nar d G, C h o uer y E, P ut orti M L, et al. M utati o ns of P O L R 3 A e nc o di n g a catal ytic 
s u b u nit of R N A p ol y merase P ol III ca use a recessi ve h y p o m yeli nati n g le u k o d ystr o p h y. 
A meric a n j o ur n al of h u m a n ge netics  2 0 1 1; 8 9 ( 3): 4 1 5-2 3.  
2 3.  Da o u d H, Tetrea ult M, Gi bs o n W, et al. M utati o ns i n P O L R 3 A a n d P O L R 3 B are a 
maj or ca use of h y p o m yeli nati n g le u k o d ystr o p hies wit h or wit h o ut de ntal a b n or malities a n d/ or h y p o g o na d otr o pic h y p o g o na dis m. J o ur n al of me dic al ge netics  2 0 1 3; 5 0 ( 3): 1 9 4-7.  
2 4.  va n der K naa p M S, va n der V o or n P, Bar k h of F, et al. A ne w le u k oe nce p hal o pat h y 
wit h brai nste m a n d s pi [INVESTIGATOR_1304] c or d i n v ol ve me nt a n d hi g h lactate. A n n als of ne ur ol o gy  2 0 0 3; 
5 3 ( 2): 2 5 2-8.  
2 5.  Sc he per G C, va n der Kl o k T, va n A n del RJ, et al. Mit oc h o n drial as part yl -t R N A 
s y nt hetase deficie nc y ca uses le u k oe nce p hal o pat h y wit h brai n ste m a n d s pi [INVESTIGATOR_1304] c or d i n v ol ve me nt a n d lactate ele vati o n. N at ure ge netics  2 0 0 7; 3 9 ( 4): 5 3 4-9.  
2 6.  Lee g water P A, Y ua n B Q, va n der Stee n J, et al. M utati o ns of M L C 1 ( KI A A 0 0 2 7), 
e nc o di n g a p utati ve me m bra ne pr otei n, ca use me gale nce p halic le u k oe nce p hal o pat h y wit h 
s u bc ortical c ysts. A meric a n j o ur n al of h u m a n ge netics  2 0 0 1; 6 8 ( 4): 8 3 1-8.  
2 7.  L o pez -Her na n dez T, Ri d der M C, M o nt oli o M, et al. M uta nt Glial C A M ca uses 
me gale nce p halic le u k oe nce p hal o pat h y wit h s u bc ortical c ysts, be ni g n fa milial macr oce p hal y, 
a n d macr oce p hal y wit h retar dati o n a n d a utis m. A meric a n j o ur n al of h u m a n ge netics  2 0 1 1; 
8 8 ( 4): 4 2 2-3 2.  
2 8.  Stee n we g M E, Va n der ver A, Ce ule ma ns B, et al. N o vel i nfa ntile -o nset 
le u k oe nce p hal o pat h y wit h hi g h lactate le vel a n d sl o w i m pr o ve me nt. Arc hives of ne ur ol o gy  2 0 1 2; 6 9 ( 6): 7 1 8-2 2.  
2 9.  Stee n we g M E, G hezzi D, Haac k T, et al. Le u k oe nce p hal o pat h y wit h t hala m us a n d 
brai nste m i n v ol ve me nt a n d hi g h lactate ' L T B L' ca use d b y E A R S 2 m utati o ns. Br ai n : a 
j o ur n al of ne ur ol o gy 2 0 1 2; 1 3 5 ( Pt 5): 1 3 8 7-9 4.  
3 0.  Taft RJ, Va n der ver A, Le ve nter RJ, et al. M utati o ns i n D A R S ca use 
h y p o m yeli nati o n wit h brai n ste m a n d s pi [INVESTIGATOR_1304] c or d i n v ol ve me nt a n d le g s pasticit y. A meric a n 
j o ur n al of h u m a n ge netics 2 0 1 3; 9 2 ( 5): 7 7 4-8 0.  
3 1.  Si m o ns C, W olf NI, Mc Neil N, et al. A de n o v o m utati o n i n t he beta -t u b uli n ge ne 
T U B B 4 A res ults i n t he le u k oe nce p hal o pat h y h y p o m yeli nati o n wit h atr o p h y of t he basal ga n glia a n d cere bell u m. A meric a n j o ur n al of h u m a n ge netics  2 0 1 3; 9 2 ( 5): 7 6 7-7 3.  
   1 9  
3 2.  Va n der ver A, Hat h o ut Y, Malet k o vic J, et al. Se nsiti vit y a n d s pecificit y of decrease d 
C S F asial otra nsferri n f or eI F 2 B -relate d dis or der. Ne ur ol o gy  2 0 0 8; 7 0 ( 2 3): 2 2 2 6-3 2.  
3 3.  Va n der ver A, Sc hiff ma n n R, Ti m m o ns M, et al. Decrease d asial otra nsferri n i n 
cere br os pi [INVESTIGATOR_55498] d of patie nts wit h c hil d h o o d -o nset ata xia a n d ce ntral ner v o us s yste m h y p o m yeli nati o n/ va nis hi n g w hite matter disease. Cli nic al c he mistry  2 0 0 5; 5 1 ( 1 1): [ADDRESS_417150] o me. A meric a n j o ur n al of h u m a n ge netics  2 0 0 7; 8 1 ( 4): [ADDRESS_417151] o me 
i m plicate S A M H D 1 as re g ulat or of t he i n nate i m m u ne res p o nse. N at ure ge netics  2 0 0 9; 
4 1 ( 7): [ADDRESS_417152] ora ge diseases. Ne ur ol o gy ; 7 4 ( 4): 3 0 2-5.  
3 7.  M oc hel F, Se del F, Va n der ver A, et al. Cere bellar ata xia wit h ele vate d cere br os pi [INVESTIGATOR_337599] d ( C A F S A). Br ai n : a j o ur n al of ne ur ol o gy  2 0 0 9; 1 3 2 ( Pt 3): 8 0 1-9.  
3 8.  G or os pe J R, Si n g hal B S, Kai n u T, et al. I n dia n A gar wal me gale nce p halic 
le u k o d ystr o p h y wit h c ysts is ca use d b y a c o m m o n M L C 1 m utati o n. Ne ur ol o gy  2 0 0 4; 6 2 ( 6): 
8 7 8 -8 2.  
3 9.  Sc hiff ma n n R, B oes pfl u g -Ta n g u y O. A n u p date o n t he le u k o ds ytr o p hies. C urr O pi n 
Ne ur ol  2 0 0 1; 1 4 ( 6): 7 8 9-9 4.  
4 0.  Si n g hal B S. Le u k o d ystr o p hies: I n dia n sce nari o. I n di a n J Pe di atr 2 0 0 5; 7 2 ( 4): [ADDRESS_417153]  2 0 0 7; 2 3 ( 4): 4 6 5-8.  
4 2.  Val k J. I n dia n A gar wal me gale nce p halic le u k o d ystr o p h y wit h c ysts is ca use d b y a 
c o m m o n M L C 1 m utati o n. Ne ur ol o gy  2 0 0 4; 6 3 ( 1 1): 2 1 9 7; a ut h or re pl y  
4 3.  Li n na n ki vi T, L u n d b o m N, A utti T, et al. Fi ve ne w cases of a rece ntl y descri be d 
le u k oe nce p hal o pat h y wit h hi g h brai n lactate. Ne ur ol o gy  2 0 0 4; 6 3 ( 4): 6 8 8-9 2.  
4 4.  va n der K naa p M S, Li n na n ki vi T, Paeta u A, et al. H y p o m yeli nati o n wit h atr o p h y of 
t he basal ga n glia a n d cere bell u m: f oll o w-u p a n d pat h ol o g y. Ne ur ol o gy  2 0 0 7; 6 9 ( 2): 1 6 6-7 1.  
4 5.  Va n der ver A, Si m o ns C, Hel ma n G, et al. W h ole e x o me se q ue nci n g i n patie nts wit h 
w hite matter a b n or malities. A n n als of ne ur ol o gy  2 0 1 6; 7 9 ( 6): 1 0 3 1-7.  
4 6.  Sc hiff ma n n R, va n der K naa p M S. I n vite d article: a n M RI -base d a p pr oac h t o t he 
dia g n osis of w hite matter dis or ders. Ne ur ol o gy  2 0 0 9; 7 2 ( 8): 7 5 0-9.  
  
 